Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Meta Platforms heads into its October 21 earnings report with an unusual split: the stock has recovered sharply from its mid-October trough, analysts are mostly raising targets, and yet Goldman Sachs cut its price target to $762 this morning, landing almost exactly at the current price.
The Goldman move is the standout of the week. Eric Sheridan maintained his Buy rating but cut the target from $860 to $762, a $98 reduction that arrived on the same day the stock closed at $762.50. That brings Goldman's target to a near-zero premium to market, which is a meaningfully cautious signal even with the Buy rating intact. It contrasts sharply with the rest of the analyst pack. UBS raised its target to $884 from $715 this morning. Guggenheim lifted to $850 from $700. Yesterday, Truist pushed to $1,000 from $763 and Pivotal Research moved to $930 from $790. The consensus mean is $813.65, implying about 7% upside from current levels. The direction of travel for most of the Street remains firmly bullish, making Goldman's cut the lone dissenting note in an otherwise uniform chorus of raises.
Short interest is not the story here, but it is worth a sentence. Shorts climbed 8% on the week to 1.54% of free float, continuing the acceleration flagged in the October 12 note. That is the highest level since mid-August, and the one-month increase now stands at 19%. Even so, the borrow market is completely relaxed. Availability is near its ceiling, with more than 2.1 billion shares available to lend against roughly 33 million borrowed. Cost to borrow is 0.32%, barely above zero. The short interest build is a positioning note, not a squeeze risk.
Options traders are marginally more cautious than usual, but not dramatically so. The put/call ratio is 0.493, above its 20-day average of 0.477 by less than one standard deviation. The 52-week range runs from 0.41 to 0.72, which puts the current reading toward the calm end of the spectrum. Options positioning does not look like a market bracing for a rough print.
The earnings history adds context worth carrying. The last two quarterly prints both produced a negative next-day move: the July 2026 report sent the stock down 9.2% the following session, and the prior print fell 5.9%. The five-day moves were more muted, with the July result nearly flat by the end of the week. That pattern suggests the stock has tended to price in a lot before the release, then sell the fact, before recovering. The stock has gained 3.2% this week and 17.7% over the past month, meaning it arrives at earnings with significant recent appreciation already embedded.
The bull case rests on 3.6 billion daily active users, Muse AI reaching the top of the iOS App Store with 15 million subscriptions and trials, and advertising ROI continuing to improve across Reels and WhatsApp. The bear case centres on the $130 billion to $145 billion in planned 2026 capital expenditure, the ongoing $4.62 billion quarterly operating loss at Reality Labs, and the risk that engagement among younger users softens. The PE multiple has expanded by about three points over the past month to 22.6x, reflecting the stock's strong run. Forward earnings growth ranks in the 84th percentile, but near-term EPS momentum is softer, sitting in the 28th percentile on a 30-day basis.
With seven days to the print, the central question is whether the Street's target-price enthusiasm translates into a positive reaction, or whether a stock that has rallied 18% in a month faces the same sell-the-news dynamic that defined the last two earnings days.
See the live data behind this article on ORTEX.
Open META on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
